Loading…
Genesys International Corporation (GENESYS)₹188.11−1.57%IT Enabled Services
In the Jun 2026 quarter (consolidated), Genesys International Corporation reported sales of ₹81.13 Cr, up 14.8% from Jun 2025, and net profit of ₹5.27 Cr, down 24.4% year on year. For the year to Mar 2026, sales were ₹327 Cr and net profit ₹32.95 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 33.08 | 59.16 | 70.96 | 55.65 | 71.85 | 88.92 | 93.87 | 70.66 | 76.73 | 75.56 | 104 | 81.13 |
| Expenses | 25.42 | 28.48 | 34.80 | 35.24 | 42.50 | 46.38 | 44.27 | 41.28 | 46.82 | 59.86 | 69.98 | 53.07 |
| Operating Profit | 7.69 | 30.75 | 36.19 | 20.40 | 29.32 | 42.52 | 49.69 | 29.47 | 29.97 | 15.72 | 34.04 | 28.10 |
| OPM % | 23.2% | 51.9% | 51.0% | 36.6% | 40.8% | 47.7% | 52.9% | 41.6% | 39.0% | 20.8% | 32.7% | 34.6% |
| Other Income | 1.10 | 2.52 | 0.45 | 1.40 | 0.99 | 1.83 | 0.10 | 1.26 | 3.83 | 6.02 | 3.44 | 1.75 |
| Interest | 0.73 | 1.10 | 1.44 | 1.25 | 1.89 | 2.59 | 3.09 | 3.19 | 3.11 | 2.85 | 3.36 | 3.15 |
| Depreciation | 10.93 | 11.05 | 11.17 | 11.79 | 12.24 | 15.67 | 15.27 | 15.44 | 15.61 | 16.82 | 17.12 | 18.42 |
| Profit before tax | −2.86 | 21.25 | 24.18 | 8.81 | 16.31 | 26.25 | 31.63 | 12.20 | 15.18 | 2.14 | 17.14 | 8.35 |
| Tax % | 20.7% | 25.7% | 38.6% | 39.6% | 31.7% | 20.7% | 39.7% | 42.6% | 20.2% | 50.6% | 25.5% | 36.5% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −4.03 | 0.00 | 0.00 |
| Net Profit | −3.42 | 15.71 | 14.77 | 5.29 | 11.08 | 20.68 | 18.99 | 6.97 | 12.04 | 1.04 | 12.70 | 5.27 |
| EPS (Rs) | −0.56 | 2.63 | 2.36 | 0.86 | 1.78 | 3.26 | 2.98 | 1.08 | 1.81 | 0.17 | 1.86 | 0.81 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 46.84 | 63.85 | 114 | 115 | 112 | 79.84 | 120 | 180 | 197 | 310 | 327 | 337 |
| Expenses | 39.86 | 47.83 | 77.77 | 95.75 | 97.77 | 80.73 | 91.76 | 122 | 117 | 168 | 218 | 230 |
| Operating Profit | 6.99 | 15.96 | 35.95 | 18.98 | 12.98 | −1.99 | 27.96 | 58.95 | 80.86 | 143 | 109 | 108 |
| OPM % | 16.0% | 25.0% | 32.0% | 17.0% | 12.0% | −1.9% | 23.0% | 32.0% | 41.0% | 46.0% | 33.0% | 32.0% |
| Other Income | 5.99 | 2.99 | 3.99 | 2.99 | 3.99 | −29.98 | −41.93 | 5.99 | 4.99 | 3.99 | 14.97 | 15.04 |
| Interest | 2.01 | 2.01 | 2.01 | 3.01 | 3.01 | 4.01 | 3.01 | 3.01 | 5.01 | 10.04 | 12.04 | 12.47 |
| Depreciation | 7.01 | 12.99 | 13.99 | 18.99 | 20.99 | 18.99 | 18.99 | 36.98 | 43.98 | 54.94 | 65.01 | 67.97 |
| Profit before tax | 5.02 | 5.01 | 24.08 | 0.00 | −7.03 | −54.18 | −36.14 | 25.09 | 37.12 | 83.32 | 46.13 | 42.81 |
| Tax % | 6.0% | −41.0% | 28.0% | 1,108.0% | −23.0% | −5.0% | 11.0% | 40.0% | 42.0% | 32.0% | 29.0% | — |
| Exceptional items | −0.05 | −0.07 | 0.00 | −1.36 | 0.07 | −30.80 | −48.91 | 1.20 | 0.73 | 0.02 | −3.61 | −4.03 |
| Net Profit | 1.99 | 5.99 | 16.99 | −3.99 | −4.99 | −51.97 | −39.98 | 14.98 | 21.97 | 55.98 | 32.95 | 31.05 |
| EPS (Rs) | 0.47 | 1.33 | 3.46 | 1.09 | 0.39 | −8.63 | 2.68 | 3.17 | 3.50 | 8.86 | 4.89 | 4.65 |
| Dividend payout % | 17.0% | 6.0% | 2.0% | 7.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14.97 | 14.97 | 14.97 | 14.97 | 15.98 | 15.97 | 15.97 | 15.98 | 18.97 | 20.00 | 19.99 | 21.03 |
| Reserves | 193 | 195 | 152 | 209 | 208 | 197 | 158 | 189 | 387 | 469 | 535 | 683 |
| Borrowings | 11.99 | 14.01 | 21.99 | 24.02 | 26.01 | 16.01 | 14.01 | 26.03 | 39.03 | 60.10 | 122 | 173 |
| Other Liabilities | 25.11 | 37.02 | 135 | 136 | 134 | 136 | 117 | 88.41 | 61.29 | 86.41 | 100 | 96.46 |
| Total Liabilities | 244 | 262 | 324 | 385 | 383 | 365 | 304 | 319 | 506 | 635 | 778 | 973 |
| Fixed Assets | 20.98 | 21.99 | 179 | 217 | 208 | 203 | 194 | 138 | 157 | 156 | 128 | 287 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 18.95 | 64.92 | 113 | 156 | 0.99 |
| Investments | 122 | 156 | 24.93 | 10.97 | 10.98 | 14.96 | 7.98 | 5.98 | 50.83 | 0.00 | 0.00 | 0.00 |
| Other Assets | 101 | 84.10 | 120 | 157 | 165 | 147 | 102 | 156 | 232 | 366 | 495 | 685 |
| Trade receivables | 56.84 | 27.90 | 22.92 | 41.84 | 58.84 | 46.84 | 31.91 | 48.85 | 82.66 | 142 | 221 | 202 |
| Cash & equivalents | 3.01 | 4.01 | 20.99 | 38.03 | 4.01 | 3.01 | 3.01 | 22.01 | 18.01 | 76.10 | 18.02 | 104 |
| Total Assets | 244 | 262 | 324 | 385 | 383 | 365 | 304 | 319 | 506 | 635 | 778 | 973 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 1.01 | 45.03 | −3.01 | 17.02 | −23.03 | 31.05 | 19.03 | 28.04 | −35.05 | 19.03 | −53.07 | 16.03 |
| Cash from investing activity | −3.99 | −41.99 | 12.99 | −37.01 | −16.99 | −14.99 | −11.99 | −20.01 | −188 | −79.98 | −18.01 | −150 |
| Cash from financing activity | 2.99 | −1.99 | 3.99 | 37.89 | 6.99 | −13.96 | −7.98 | 11.97 | 215 | 70.86 | 49.89 | 139 |
| Net cash flow | 0.00 | 1.01 | 14.01 | 16.99 | −33.99 | 2.01 | −1.01 | 20.01 | −9.01 | 11.01 | −20.02 | 4.99 |
| Capex | 4.99 | 7.98 | 9.98 | 51.86 | 29.94 | 10.97 | 8.98 | 13.96 | 52.91 | 42.88 | 13.96 | 36.90 |
| Free cash flow | −4.01 | 37.13 | −5.01 | −35.11 | −51.12 | 19.06 | 10.04 | 6.01 | −133 | −64.20 | −107 | −43.13 |
| CFO / OP % | 12.0% | 617.0% | −12.0% | 60.0% | −82.0% | 263.0% | −1,321.0% | 111.0% | −49.0% | 26.0% | −29.0% | 32.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 344 | 220 | 133 | 135 | 187 | 156 | 149 | 151 | 169 | 264 | 262 | 227 |
| Cash conversion cycle | 342 | 218 | 131 | 133 | 185 | 154 | 147 | 149 | 167 | 262 | 260 | 225 |
| Working capital days | 326 | 172 | 105 | 99 | 215 | 223 | 126 | 82 | 212 | 269 | 291 | 317 |
| ROCE % | — | 3.0% | 3.0% | 8.0% | 1.0% | −1.0% | −7.0% | 4.0% | 7.0% | 8.0% | 14.9% | 8.0% |
For the Jun 2026 quarter, Genesys International Corporation reported sales of ₹81.13 Cr, up 14.8% year on year and net profit of ₹5.27 Cr, down 24.4% year on year. The operating margin was 34.6%.
Genesys International Corporation's sales for the year to Mar 2026 were ₹327 Cr; over the last twelve months they were ₹337 Cr.
Net profit for the year to Mar 2026 was ₹32.95 Cr, and ₹31.05 Cr over the last twelve months. Earnings per share over the same trailing period were ₹4.65.
Genesys International Corporation reported borrowings of ₹173 Cr at Mar 2026, against cash and equivalents of ₹104 Cr.
Cash from operations was ₹16.03 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹43.13 Cr.